Arcellx, Inc. (ACLX)
72.71
+0.73
(+1.01%)
USD |
NASDAQ |
Dec 11, 16:00
72.71
0.00 (0.00%)
After-Hours: 19:42
Arcellx Free Cash Flow: -201.18M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.162B |
| Geron Corp. | -132.68M |
| Daré Bioscience, Inc. | -17.15M |
| Cartesian Therapeutics, Inc. | -52.84M |
| Cabaletta Bio, Inc. | -120.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.21M |
| Cash from Investing (Quarterly) | -20.03M |
| Cash from Financing (Quarterly) | 86.10M |
| Free Cash Flow Per Share (Quarterly) | -0.8748 |
| Free Cash Flow to Equity (Quarterly) | -48.78M |
| Free Cash Flow to Firm (Quarterly) | -49.50M |
| Free Cash Flow Yield | -4.98% |